GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
73.81
+4.43 (6.39%)
Nov 21, 2024, 1:22 PM EST - Market open
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.04 billion as of November 21, 2024. Its market cap has increased by 4,705.42% in one year.
Market Cap
2.04B
Enterprise Value
1.91B
1-Year Change
4,705.42%
Ranking
Category
Stock Price
$74.34
Market Cap Chart
Since September 2, 2020, GeneDx Holdings's market cap has increased from $448.40M to $2.04B, an increase of 355.46%. That is a compound annual growth rate of 43.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.95B | 2,641.01% |
| Dec 29, 2023 | 71.20M | -30.20% |
| Dec 30, 2022 | 102.00M | -90.52% |
| Dec 31, 2021 | 1.08B | 76.10% |
| Dec 31, 2020 | 611.00M | 36.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.01B |
| Astrana Health | 2.01B |
| NeoGenomics | 1.97B |
| Omnicell | 1.96B |
| Supernus Pharmaceuticals | 1.96B |
| National HealthCare | 1.92B |
| MannKind | 1.89B |
| Structure Therapeutics | 1.87B |